Potent benzoazepinone γ-secretase modulators with improved bioavailability
Authors:
- 1 September 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (17) , 3495-3500
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Structure of a presenilin family intramembrane aspartate proteaseNature, 2012
- γ-Secretase Modulator in Alzheimer's Disease: Shifting the EndJournal of Alzheimer’s Disease, 2012
- BMS-708,163 Targets Presenilin and Lacks Notch-Sparing ActivityBiochemistry, 2012
- γ‐Secretase inhibitors and modulators for Alzheimer’s diseaseJournal of Neurochemistry, 2011
- Discovery of BIIB042, a Potent, Selective, and Orally Bioavailable γ-Secretase ModulatorACS Medicinal Chemistry Letters, 2011
- Chronic treatment with a novel γ‐secretase modulator, JNJ‐40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's diseaseBritish Journal of Pharmacology, 2011
- γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer’s DrugsJournal of Medicinal Chemistry, 2010
- Secretase inhibitors and modulators for Alzheimer’s disease treatmentExpert Review of Neurotherapeutics, 2009
- Generation of Aβ38 and Aβ42 Is Independently and Differentially Affected by Familial Alzheimer Disease-associated Presenilin Mutations and γ-Secretase ModulationJournal of Biological Chemistry, 2008
- γ-Secretase: Structure, Function, and Modulation for Alzheimers DiseaseCurrent Topics in Medicinal Chemistry, 2008